Stem cell regeneration repairs congenital heart defect

September 12, 2008

Potential therapy for inherited conditions

ROCHESTER, Minn. -- Mayo Clinic investigators have demonstrated that stem cells can be used to regenerate heart tissue to treat dilated cardiomyopathy, a congenital defect. Publication of the discovery was expedited by the editors of Stem Cells and appeared online in the "express" section of the journal's Web site at http://stemcells.alphamedpress.org/.

The study expands on the use of embryonic stem cells to regenerate tissue and repair damage after heart attacks and demonstrates that stem cells also can repair the inherited causes of heart failure.

"We've shown in this transgenic animal model that embryonic stem cells may offer an option in repairing genetic heart problems," says Satsuki Yamada, M.D., Ph.D., cardiovascular researcher and first author of the study. "Close evaluation of genetic variations among individuals to identify optimal disease targets and customize stem cells for therapy opens a new era of personalized regenerative medicine," adds Andre Terzic, M.D., Ph.D., Mayo Clinic cardiologist and senior author and principal investigator.

How They Did It

The team reproduced prominent features of human malignant heart failure in a series of genetically altered mice. Specifically, the "knockout" of a critical heart-protective protein known as the KATP channel compromised heart contractions and caused ventricular dilation or heart enlargement. The condition, including poor survival, is typical of patients with heritable dilated cardiomyopathy.

Researchers transplanted 200,000 embryonic stem cells into the wall of the left ventricle of the knockout mice. After one month the treatment improved heart performance, synchronized electrical impulses and stopped heart deterioration, ultimately saving the animal's life. Stem cells had grafted into the heart and formed new cardiac tissue. Additionally, the stem cell transplantation restarted cell cycle activity and halved the fibrosis that had been developing after the initial damage. Stem cell therapy also increased stamina and removed fluid buildup in the body, so characteristic in heart failure.

The researchers say their findings show that stem cells can achieve functional repair in non-ischemic (cases other than blood-flow blockages) genetic cardiomyopathy. Further testing is underway.

Mayo Clinic

---

---

	Hypertrophic Cardiomyopathy: For Patients, Their Families and Interested Physicians by Barry J. Maron (Author), Lisa Salberg (Author) When there is a diagnosis of HCM in a family, this complete, easy-to-read guide is your essential resource for finding the answers to your many questions. In clear and straightforward language, it explains what hypertrophic cardiomyopathy is, what the symptoms are, and how it can be treated, as well as reviewing the genetic implications and offering candid lifestyle advice. Drawing on the expertise of Dr. Barry Maron, an internationally recognized authority on HCM, the book addresses major questions and concerns of both patients and families. Fully revised to reflect the latest developments, Hypertrophic Cardiomyopathy: For patients, their families and interested physicians, Second Edition, is a valuable source of straightforward advice and dependable information for everyone who...
	Genetics of Cardiomyopathy and Heart Failure, An Issue of Heart Failure Clinics, 1e (The Clinics: Internal Medicine) by Calum MacRae MD PhD (Author) This issue explores the genetic basis of specific cardiomyopathies and  phenotypic components of heart failure with an eye to the clinical implications of this genetic knowledge.  An understanding of the genetic causes of disease can aid in development of effective prevention and management strategies.
	Heartfelt: Caregiver's Guide to Cardiomyopathy and Mitral Valve Surgery by Elaine Webster (Author) The past twenty years have seen major advances in open-heart surgery. What was once considered a death sentence is now often curable. This is especially true with valve-repair and replacement surgeries. As caregiver for a heart patient, you face unique challenges. You must be friend, confidant, patient advocate, spiritual advisor, and nurse to your patient, all the while trying to keep your own life together. Heartfelt chronicles sixteen years of the author’s life with her husband Blake as they struggle through his first major arrhythmia, to mitral-valve repair surgery, and onto recovery. Through Webster’s personal insights and common-sense advice, you’ll learn how to: Take Care of Your Patient: Find the right medical team, Research hospitals, Track down affordable health...
	Cardiomyopathies: Causes, Effects and Treatment by Peter H. Bruno (Editor), Matthew T. Giordano (Editor) Cardiomyopathy is a type of heart disease in which the heart becomes abnormally enlarged, thickened and/or stiffened. As a result, the heart muscle's ability to pump and/or receive blood is impaired. This book describes the most recent advances in cardiomyopathies- one of the leading causes of hospitalisation worldwide. Dilated cardiomyopathy (DCM), also known as congestive cardiomyopathy, is a condition in which the heart becomes weakened and enlarged, and as a result, cannot pump blood efficiently. The causes, effects, as well as the severity of DCM are described in this book, as well as the types of therapy that are effective, such as anti-inflammatory or immunosuppressive therapy. There has been a general decrease of cardiac involvement in HIV-positive subjects in recent years due...
	Complete Medical Guide and Prevention for Heart Disease Volume IX; Cardiomyopathy by New Creative Heart is a muscular organ that located the center of the circulatory system. It pumps blood throughout body via blood vessels network, such as capillaries, arteries and veins. Blood is delivered to and from all parts of body by these blood vessels. At the optimal rate required to function well, a healthy heart provides your entire body with the proper quantity of blood. If disease or injury impairs your heart, your body's organs won't obtain enough blood to operate regularly. Cardiopathy, commonly known as cardiac disease or heart disease, is an hyponym for a various diseases affecting the heart. Since 2007, it is one of the major cause of death in the United States, Canada and some European countries such as England and Wales, representing about 25.4% of the total...
	Success with Heart Failure (mass mkt ed): Help and Hope for Those with Congestive Heart Failure by Marc Silver (Author) Up-to-date information on available and forthcoming medical and surgical treatments. How attitude and emotion affect heart failure-and what you can do to stay positive. Tips for adopting a heart-healthy diet and lifestyle. Ways to forge a positive working relationship with your doctor or cardiologist.
	The Official Patient's Sourcebook on Dilated Cardiomyopathy by James N. Parker (Editor), Philip M. Parker (Editor) This book has been created for patients who have decided to make education and research an integral part of the treatment process. Although it also gives information useful to doctors, caregivers and other health professionals, it tells patients where and how to look for information covering virtually all topics related to dilated cardiomyopathy (also cardiomyopathy - dilated; congestive cardiomyopathy), from the essentials to the most advanced areas of research. The title of this book includes the word official. This reflects the fact that the sourcebook draws from public, academic, government, and peer-reviewed research. Selected readings from various agencies are reproduced to give you some of the latest official information available to date on dilated cardiomyopathy. Given patients'...
	Should all patients with cardiomyopathy have coronary angiography?(Pro & Con): An article from: Family Practice News by Stephen J. Green (Author), Avijit Lahiri (Author) This digital document is an article from Family Practice News, published by International Medical News Group on April 15, 2005. The length of the article is 825 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Should all patients with cardiomyopathy have coronary angiography?(Pro & Con) Author: Stephen J. Green Publication: Family Practice News (Magazine/Journal) Date: April 15, 2005 Publisher: International Medical News Group Volume: 35 Issue: 8 Page: 10(1) Distributed by Thomson...
	Cardiac Magnetic Resonance Imaging as a Prognostic Tool in Patients with Nonischemic Cardiomyopathy (Hospital Practice) by JTE Multimedia Technical advancements have enabled cardiac magnetic resonance (CMR) imaging to provide a noninvasive assessment of cardiomyopathy. Cardiac magnetic resonance imaging acts as the reference standard for quantifying left and right ventricular function. It also assesses the etiology of cardiomyopathy by demonstrating the presence and size of myocardial scar and by detecting myocardial inflammation and interstitial infiltration. Cardiomyopathy can result in early mortality and arrhythmic risk, and CMR imaging aids in risk stratification among this group of patients. Left ventricular ejection fraction predicts which patients will benefit most from implantable cardioverter-defibrillators (ICDs), but this is not a perfect marker of arrhythmic risk. The etiology of cardiomyopathy, as assessed...
	Anthracycline-Induced Cardiomyopathy (Postgraduate Medicine) by JTE Multimedia Abstract: Anthracyclines are potent chemotherapeutic agents associated with 3 different forms of cardiomyopathy. Acute cardiomyopathy is seen within 3 months of drug exposure and may take the form of either a reversible myocarditis and pericarditis or an early-onset type and a late-onset type of chronic cardiomyopathy. Chronic anthracycline-induced cardiomyopathy is treated similarly to ischemic cardiomyopathies with beta-blockade and angiotensin-converting enzyme (ACE) inhibition. This review focuses on recent research regarding mechanisms of anthracycline-induced myocardial damage, the noninvasive imaging diagnosis of anthracycline-induced cardiomyopathy, and potential areas of future research regarding genetic screening and selecting individuals at increased risk, with consideration of...